相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma
H. J. Close et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Tackling the Many Facets of Glioblastoma Heterogeneity
Itay Tirosh et al.
CELL STEM CELL (2020)
Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies
Ana Rita Pombo Antunes et al.
ELIFE (2020)
Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence
Sean J. Judge et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Functional and metabolic targeting of natural killer cells to solid tumors
Jiao Wang et al.
CELLULAR ONCOLOGY (2020)
Management of glioblastoma: State of the art and future directions
Aaron C. Tan et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma
Syreeta DeCordova et al.
FRONTIERS IN IMMUNOLOGY (2020)
Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis
Shuo Zhang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor
Ying Gong et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
Bassel Nazha et al.
FRONTIERS IN ONCOLOGY (2020)
Chloroquine against malaria, cancers and viral diseases
Wenmin Zhou et al.
DRUG DISCOVERY TODAY (2020)
Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma
Woo Jin Kim et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
CAR T cells for brain tumors: Lessons learned and road ahead
David Akhavan et al.
IMMUNOLOGICAL REVIEWS (2019)
Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma
Monica Fedele et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
NT5E/CD73 as Correlative Factor of Patient Survival and Natural Killer Cell Infiltration in Glioblastoma
Jiao Wang et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Patient-Derived Glioma Models: From Patients to Dish to Animals
Cintia Carla da Hora et al.
CELLS (2019)
Glioblastoma: Targeting the autophagy in tumorigenesis
Kang Yang et al.
BRAIN RESEARCH BULLETIN (2019)
Targeting Autophagy for Cancer Treatment and Tumor Chemosensitization
Marta Perez-Hernandez et al.
CANCERS (2019)
Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy
Pavlina Chuntova et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors
Andrea M. Chambers et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2019)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Karolina Woroniecka et al.
CLINICAL CANCER RESEARCH (2018)
NKG2D ligands in glioma stem-like cells: expression in situ and in vitro
Charlotte Flueh et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2018)
Temozolomide, sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cells
Sanford Hsu et al.
Oncotarget (2018)
Adenosinergic signaling as a target for natural killer cell immunotherapy
Jiao Wang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
Re-purposing Chloroquine for Glioblastoma: Potential Merits and Confounding Variables
Patrick Weyerhauser et al.
FRONTIERS IN ONCOLOGY (2018)
Adenosinergic Signaling Alters Natural Killer Cell Functional Responses
Andrea M. Chambers et al.
FRONTIERS IN IMMUNOLOGY (2018)
Purinergic targeting enhances immunotherapy of CD73(+) solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells
Jiao Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma
Tobias Weiss et al.
CLINICAL CANCER RESEARCH (2018)
Immunotherapy for Brain Tumors
John H. Sampson et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Development of a direct contact astrocyte-human cerebral microvessel endothelial cells blood-brain barrier coculture model
Chris Kulczar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2017)
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller et al.
LANCET ONCOLOGY (2017)
RANDOMIZED PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF NIVOLUMAB VS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: CHECKMATE 143
D. A. Reardona et al.
NEURO-ONCOLOGY (2017)
Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner
Takouhie Mgrditchian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma A Phase 1 Dose-Escalation Trial
Nabil Ahmed et al.
JAMA ONCOLOGY (2017)
Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival
Sabrina Genssler et al.
ONCOIMMUNOLOGY (2016)
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells
Alan L. Chang et al.
CANCER RESEARCH (2016)
Targeting autophagy to sensitive glioma to temozolomide treatment
Yuanliang Yan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Glycolipid GD3 and GD3 synthase are key drivers for glioblastoma stem cells and tumorigenicity
Shih-Chi Yeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
Christine E. Brown et al.
CLINICAL CANCER RESEARCH (2015)
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
Nadja Müller et al.
JOURNAL OF IMMUNOTHERAPY (2015)
CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
Jianfeng Han et al.
SCIENTIFIC REPORTS (2015)
Hydroxychloroquine Inhibits Autophagy to Potentiate Antiestrogen Responsiveness in ER+ Breast Cancer
Katherine L. Cook et al.
CLINICAL CANCER RESEARCH (2014)
Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours
Justyna Kmiecik et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Regulation of Ligands for the NKG2D Activating Receptor
David H. Raulet et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index
Luc R. Desnoyers et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells
Jingjing Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8(+) T cells glioma patients
Courtney A. Crane et al.
NEURO-ONCOLOGY (2010)
Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice
MA Taylor et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
